{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:14:31Z","timestamp":1795025671111,"version":"4.10.2"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The endogenous repair process can result in recovery after acute kidney injury (AKI)\u00a0with adaptive proliferation of tubular epithelial cells, but repair can also lead to fibrosis and progressive kidney disease. There is currently limited knowledge about transcriptional regulators regulating these repair programs. Herein we establish the enhancer and super-enhancer landscape after AKI by ChIP-seq in uninjured and repairing kidneys on day two after ischemia reperfusion injury (IRI). We identify key transcription factors including HNF4A, GR, STAT3 and STAT5, which show specific binding at enhancer and super-enhancer sites, revealing enhancer dynamics and transcriptional changes during kidney repair. Loss of bromodomain-containing protein 4 function before IRI leads to impaired recovery after AKI and increased mortality. Our comprehensive analysis of epigenetic changes after kidney injury in vivo has the potential to identify targets for therapeutic intervention. Importantly, our data also call attention to potential caveats involved in use of BET inhibitors in patients at risk for AKI.<\/jats:p>","DOI":"10.1038\/s41467-020-17205-5","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T10:04:08Z","timestamp":1594116248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Enhancer and super-enhancer dynamics in repair after ischemic acute kidney injury"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0230-9349","authenticated-orcid":false,"given":"Julia","family":"Wilflingseder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2248-1998","authenticated-orcid":false,"given":"Michaela","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7785-5942","authenticated-orcid":false,"given":"Hye Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9911-9201","authenticated-orcid":false,"given":"Hannes","family":"Olauson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Jankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0801-6958","authenticated-orcid":false,"given":"Reinhold","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-9231","authenticated-orcid":false,"given":"M. Todd","family":"Valerius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Hennighausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-386X","authenticated-orcid":false,"given":"Joseph V.","family":"Bonventre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"key":"17205_CR1","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1681\/ASN.2004090740","volume":"16","author":"GM Chertow","year":"2005","unstructured":"Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V. & Bates, D. W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 16, 3365\u20133370 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"17205_CR2","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh, J. et al. Prevalence of chronic kidney disease in the United States. JAMA 298, 2038\u20132047 (2007).","journal-title":"JAMA"},{"key":"17205_CR3","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1056\/NEJMra1613984","volume":"376","author":"MH Rosner","year":"2017","unstructured":"Rosner, M. H. & Perazella, M. A. Acute kidney injury in patients with cancer. N. Engl. J. Med 376, 1770\u20131781 (2017).","journal-title":"N. Engl. J. Med"},{"key":"17205_CR4","doi-asserted-by":"crossref","unstructured":"Liu J. et al. Molecular characterization of the transition from acute to chronic kidney injury following ischemia\/reperfusion. JCI Insight 2, e94716 (2017).","DOI":"10.1172\/jci.insight.94716"},{"key":"17205_CR5","doi-asserted-by":"crossref","unstructured":"Yang L., Besschetnova T. Y., Brooks C. R., Shah J. V. & Bonventre J. V. Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury. Nat Med. 16, 535\u2013543 (2010).","DOI":"10.1038\/nm.2144"},{"key":"17205_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.stem.2008.01.014","volume":"2","author":"BD Humphreys","year":"2008","unstructured":"Humphreys, B. D. et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284\u2013291 (2008).","journal-title":"Cell Stem Cell"},{"key":"17205_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.celrep.2015.07.034","volume":"12","author":"S Kumar","year":"2015","unstructured":"Kumar, S. et al. Sox9 activation highlights a cellular pathway of renal repair in the acutely injured mammalian kidney. Cell Rep. 12, 1325\u20131338 (2015).","journal-title":"Cell Rep."},{"key":"17205_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrneph.2016.169","volume":"13","author":"M Chang-Panesso","year":"2017","unstructured":"Chang-Panesso, M. & Humphreys, B. D. Cellular plasticity in kidney injury and repair. Nat. Rev. Nephrol. 13, 39\u201346 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"17205_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"TE Consortium","year":"2012","unstructured":"Consortium, T. E. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"17205_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"A Kundaje","year":"2015","unstructured":"Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317\u2013330 (2015).","journal-title":"Nature"},{"key":"17205_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41586-018-0836-1","volume":"565","author":"AJM Larsson","year":"2019","unstructured":"Larsson, A. J. M. et al. Genomic encoding of transcriptional burst kinetics. Nature 565, 251\u2013254 (2019).","journal-title":"Nature"},{"key":"17205_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.tig.2012.03.006","volume":"28","author":"M Lagha","year":"2012","unstructured":"Lagha, M., Bothma, J. P. & Levine, M. Mechanisms of transcriptional precision in animal development. Trends Genet. 28, 409\u2013416 (2012).","journal-title":"Trends Genet."},{"key":"17205_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nature08451","volume":"461","author":"A Visel","year":"2009","unstructured":"Visel, A., Rubin, E. M. & Pennacchio, L. A. Genomic views of distant-acting enhancers. Nature 461, 199\u2013205 (2009).","journal-title":"Nature"},{"key":"17205_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.1257493","volume":"346","author":"N Lonfat","year":"2014","unstructured":"Lonfat, N., Montavon, T., Darbellay, F., Gitto, S. & Duboule, D. Convergent evolution of complex regulatory landscapes and pleiotropy at Hox loci. Science 346, 1004\u20131006 (2014).","journal-title":"Science"},{"key":"17205_CR15","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1178357","volume":"326","author":"M Rebeiz","year":"2009","unstructured":"Rebeiz, M., Pool, J. E., Kassner, V. A., Aquadro, C. F. & Carroll, S. B. Stepwise modification of a modular enhancer underlies adaptation in a Drosophila population. Science 326, 1663\u20131667 (2009).","journal-title":"Science"},{"key":"17205_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","volume":"149","author":"P Filippakopoulos","year":"2012","unstructured":"Filippakopoulos, P. et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214\u2013231 (2012).","journal-title":"Cell"},{"key":"17205_CR17","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1074\/jbc.M113.523019","volume":"289","author":"M Jung","year":"2014","unstructured":"Jung, M. et al. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. J. Biol. Chem. 289, 9304\u20139319 (2014).","journal-title":"J. Biol. Chem."},{"key":"17205_CR18","doi-asserted-by":"publisher","first-page":"13141","DOI":"10.1074\/jbc.R700001200","volume":"282","author":"SY Wu","year":"2007","unstructured":"Wu, S. Y. & Chiang, C. M. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 282, 13141\u201313145 (2007).","journal-title":"J. Biol. Chem."},{"key":"17205_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature13561","volume":"514","author":"T De Raedt","year":"2014","unstructured":"De Raedt, T. et al. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature 514, 247\u2013251 (2014).","journal-title":"Nature"},{"key":"17205_CR20","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"17205_CR21","doi-asserted-by":"publisher","first-page":"16669","DOI":"10.1073\/pnas.1108190108","volume":"108","author":"JA Mertz","year":"2011","unstructured":"Mertz, J. A. et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl Acad. Sci. USA 108, 16669\u201316674 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17205_CR22","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1126\/science.aar2131","volume":"360","author":"J Park","year":"2018","unstructured":"Park, J. et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360, 758\u2013763 (2018).","journal-title":"Science"},{"key":"17205_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02403-5","volume":"8","author":"JE Lee","year":"2017","unstructured":"Lee, J. E. et al. Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis. Nat. Commun. 8, 2217 (2017).","journal-title":"Nat. Commun."},{"key":"17205_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/nar\/gkw826","volume":"45","author":"Z Najafova","year":"2017","unstructured":"Najafova, Z. et al. BRD4 localization to lineage-specific enhancers is associated with a distinct transcription factor repertoire. Nucleic Acids Res. 45, 127\u2013141 (2017).","journal-title":"Nucleic Acids Res"},{"key":"17205_CR25","doi-asserted-by":"publisher","first-page":"F552","DOI":"10.1152\/ajprenal.00285.2002","volume":"286","author":"T Ichimura","year":"2004","unstructured":"Ichimura, T., Hung, C. C., Yang, S. A., Stevens, J. L. & Bonventre, J. V. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Ren. Physiol. 286, F552\u2013F563 (2004).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"17205_CR26","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","volume":"14","author":"J Mishra","year":"2003","unstructured":"Mishra, J. et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J. Am. Soc. Nephrol. 14, 2534\u20132543 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"17205_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"17205_CR28","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1172\/JCI75417","volume":"125","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. KIM-1-mediated phagocytosis reduces acute injury to the kidney. J. Clin. Invest. 125, 1620\u20131636 (2015).","journal-title":"J. Clin. Invest"},{"key":"17205_CR29","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1172\/JCI45361","volume":"123","author":"BD Humphreys","year":"2013","unstructured":"Humphreys, B. D. et al. Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J. Clin. Invest. 123, 4023\u20134035 (2013).","journal-title":"J. Clin. Invest."},{"key":"17205_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cell.2013.03.035","volume":"153","author":"WA Whyte","year":"2013","unstructured":"Whyte, W. A. et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307\u2013319 (2013).","journal-title":"Cell"},{"key":"17205_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"17205_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrneph.2014.232","volume":"11","author":"RL Clissold","year":"2015","unstructured":"Clissold, R. L., Hamilton, A. J., Hattersley, A. T., Ellard, S. & Bingham, C. HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. Nat. Rev. Nephrol. 11, 102\u2013112 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"17205_CR33","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/ncb3437","volume":"18","author":"MM Kaminski","year":"2016","unstructured":"Kaminski, M. M. et al. Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors. Nat. Cell Biol. 18, 1269\u20131280 (2016).","journal-title":"Nat. Cell Biol."},{"key":"17205_CR34","doi-asserted-by":"crossref","unstructured":"Marable S. S., Chung E., Adam M., Potter S. S. & Park J. S. Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. JCI Insight 3, e97497 (2018).","DOI":"10.1172\/jci.insight.97497"},{"key":"17205_CR35","doi-asserted-by":"publisher","first-page":"F674","DOI":"10.1152\/ajprenal.00571.2018","volume":"316","author":"RA Zager","year":"2019","unstructured":"Zager, R. A. & Johnson, A. C. M. Acute kidney injury induces dramatic p21 upregulation via a novel, glucocorticoid-activated, pathway. Am. J. Physiol. Renal Physiol. 316, F674\u2013f681 (2019).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"17205_CR36","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1681\/ASN.2013010076","volume":"24","author":"J Chen","year":"2013","unstructured":"Chen, J., Chen, J. K., Conway, E. M. & Harris, R. C. Survivin mediates renal proximal tubule recovery from AKI. J. Am. Soc. Nephrol. 24, 2023\u20132033 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"17205_CR37","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1681\/ASN.2014060612","volume":"26","author":"SC Huen","year":"2015","unstructured":"Huen, S. C. et al. GM-CSF promotes macrophage alternative activation after renal ischemia\/reperfusion injury. J. Am. Soc. Nephrol. 26, 1334\u20131345 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"17205_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","volume":"24","author":"B Chapuy","year":"2013","unstructured":"Chapuy, B. et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell 24, 777\u2013790 (2013).","journal-title":"Cancer Cell"},{"key":"17205_CR39","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"17205_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","volume":"67","author":"GE Winter","year":"2017","unstructured":"Winter, G. E. et al. BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment. Mol. Cell 67, 5\u201318 (2017). e19.","journal-title":"Mol. Cell"},{"key":"17205_CR41","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre, J. V. & Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210\u20134221 (2011).","journal-title":"J. Clin. Invest"},{"key":"17205_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.kint.2017.07.030","volume":"93","author":"S Kumar","year":"2018","unstructured":"Kumar, S. Cellular and molecular pathways of renal repair after acute kidney injury. Kidney Int. 93, 27\u201340 (2018).","journal-title":"Kidney Int."},{"key":"17205_CR43","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nsmb.2912","volume":"21","author":"T Kanno","year":"2014","unstructured":"Kanno, T. et al. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones. Nat. Struct. amp; Mol. Biol. 21, 1047\u20131057 (2014).","journal-title":"Nat. Struct. amp; Mol. Biol."},{"key":"17205_CR44","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"17205_CR45","doi-asserted-by":"crossref","unstructured":"Lemos D. R., et al. Interleukin-1beta activates a MYC-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis. J Am. Soc. Nephrol. 29,1690\u20131705 (2018).","DOI":"10.1681\/ASN.2017121283"},{"key":"17205_CR46","doi-asserted-by":"publisher","first-page":"69291","DOI":"10.18632\/oncotarget.12498","volume":"7","author":"C Xiong","year":"2016","unstructured":"Xiong, C. et al. Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis. Oncotarget 7, 69291\u201369308 (2016).","journal-title":"Oncotarget"},{"key":"17205_CR47","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.redox.2016.12.031","volume":"11","author":"B Zhou","year":"2017","unstructured":"Zhou, B. et al. Brd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-beta-mediated Nox4 expression. Redox Biol. 11, 390\u2013402 (2017).","journal-title":"Redox Biol."},{"key":"17205_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","volume":"11","author":"DA Ferenbach","year":"2015","unstructured":"Ferenbach, D. A. & Bonventre, J. V. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat. Rev. Nephrol. 11, 264\u2013276 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"17205_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1136\/jmedgenet-2013-102066","volume":"51","author":"AJ Hamilton","year":"2014","unstructured":"Hamilton, A. J. et al. The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a beta cell phenotype. J. Med Genet 51, 165\u2013169 (2014).","journal-title":"J. Med Genet"},{"key":"17205_CR50","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1073\/pnas.91.2.752","volume":"91","author":"A Ray","year":"1994","unstructured":"Ray, A. & Prefontaine, K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 91, 752\u2013756 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17205_CR51","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","volume":"54","author":"J Shi","year":"2014","unstructured":"Shi, J. & Vakoc, C. R. The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol. Cell 54, 728\u2013736 (2014).","journal-title":"Mol. Cell"},{"key":"17205_CR52","doi-asserted-by":"publisher","first-page":"101195","DOI":"10.1016\/j.redox.2019.101195","volume":"24","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Inhibition of Brd4 alleviates renal ischemia\/reperfusion injury-induced apoptosis and endoplasmic reticulum stress by blocking FoxO4-mediated oxidative stress. Redox Biol. 24, 101195 (2019).","journal-title":"Redox Biol."},{"key":"17205_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ekir.2017.12.001","volume":"3","author":"S Wasiak","year":"2018","unstructured":"Wasiak, S. et al. Benefit of apabetalone on plasma proteins in renal disease. Kidney Int. Rep. 3, 711\u2013721 (2018).","journal-title":"Kidney Int. Rep."},{"key":"17205_CR54","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/hmg\/ddv136","volume":"24","author":"X Zhou","year":"2015","unstructured":"Zhou, X. et al. Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD. Hum. Mol. Genet. 24, 3982\u20133993 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"17205_CR55","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1681\/ASN.2015080910","volume":"28","author":"B Suarez-Alvarez","year":"2017","unstructured":"Suarez-Alvarez, B. et al. Inhibition of bromodomain and extraterminal domain family proteins ameliorates experimental renal damage. J. Am. Soc. Nephrol. 28, 504\u2013519 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"17205_CR56","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.aaz8455","volume":"368","author":"O Gilan","year":"2020","unstructured":"Gilan, O. et al. Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation. Science 368, 387\u2013394 (2020).","journal-title":"Science"},{"key":"17205_CR57","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ahj.2019.08.001","volume":"217","author":"KK Ray","year":"2019","unstructured":"Ray, K. K. et al. Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am. Heart J. 217, 72\u201383 (2019).","journal-title":"Am. Heart J."},{"key":"17205_CR58","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/ng.3606","volume":"48","author":"HY Shin","year":"2016","unstructured":"Shin, H. Y. et al. Hierarchy within the mammary STAT5-driven Wap super-enhancer. Nat. Genet. 48, 904\u2013911 (2016).","journal-title":"Nat. Genet"},{"key":"17205_CR59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"17205_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"17205_CR61","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"17205_CR62","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178\u2013192 (2013).","journal-title":"Brief. Bioinform"},{"key":"17205_CR63","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ramirez","year":"2014","unstructured":"Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res"},{"key":"17205_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"17205_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"17205_CR66","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis (2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"17205_CR67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"17205_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17205-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17205-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17205-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T23:51:37Z","timestamp":1670284297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17205-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17205"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17205-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"8 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.V.B. is co-inventor on KIM-1 patents assigned to Partners Healthcare. He is co-founder of Goldfinch Bio. He is a consultant for Cadent, Aldeyra and an advisor with equity in Medibeacon Inc, Rubius, Theravance, Goldilocks, DxNow, and Sentien. All other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3383"}}